molecular_profile_name,disease_name,evidence_type,supports,does_not_support,evidence_items
ABCB1 Overexpression,Lung Non-small Cell Carcinoma,PREDICTIVE,2,1,3
ABL1 C475V,Chronic Myeloid Leukemia,PREDICTIVE,1,1,2
ABL1 L298V,Chronic Myeloid Leukemia,PREDICTIVE,1,1,2
ABL1 P-Loop Mutation,Chronic Myeloid Leukemia,PREDICTIVE,1,2,3
AKT1 E17K,Breast Cancer,PREDICTIVE,1,1,2
ALK F1174L,Neuroblastoma,PREDICTIVE,8,1,9
AR AR-V7,Prostate Cancer,PREDICTIVE,9,2,11
ATM Mutation,Castration-resistant Prostate Carcinoma,PREDICTIVE,1,1,2
ATM Mutation,Prostate Cancer,PREDICTIVE,2,1,3
ATM Underexpression,Stomach Cancer,PREDICTIVE,1,1,2
BCL2 G101V,Chronic Lymphocytic Leukemia,PREDICTIVE,5,1,6
BCR::ABL1 Fusion,Chronic Myeloid Leukemia,DIAGNOSTIC,2,1,3
BCR::ABL1 Fusion AND ABL1 A397P,Chronic Myeloid Leukemia,PREDICTIVE,2,1,3
BCR::ABL1 Fusion AND ABL1 D276G,Chronic Myeloid Leukemia,PREDICTIVE,6,2,8
BCR::ABL1 Fusion AND ABL1 E255K,Chronic Myeloid Leukemia,PREDICTIVE,19,3,22
BCR::ABL1 Fusion AND ABL1 E255V,Chronic Myeloid Leukemia,PREDICTIVE,13,4,17
BCR::ABL1 Fusion AND ABL1 E279K,Chronic Myeloid Leukemia,PREDICTIVE,3,1,4
BCR::ABL1 Fusion AND ABL1 E355G,Chronic Myeloid Leukemia,PREDICTIVE,5,5,10
BCR::ABL1 Fusion AND ABL1 E450V,Chronic Myeloid Leukemia,PREDICTIVE,1,1,2
BCR::ABL1 Fusion AND ABL1 E453A,Chronic Myeloid Leukemia,PREDICTIVE,1,1,2
BCR::ABL1 Fusion AND ABL1 E453K,Chronic Myeloid Leukemia,PREDICTIVE,1,1,2
BCR::ABL1 Fusion AND ABL1 E459K,Chronic Myeloid Leukemia,PREDICTIVE,2,2,4
BCR::ABL1 Fusion AND ABL1 E98G,Chronic Myeloid Leukemia,PREDICTIVE,1,1,2
BCR::ABL1 Fusion AND ABL1 F311I,Chronic Myeloid Leukemia,PREDICTIVE,2,1,3
BCR::ABL1 Fusion AND ABL1 F311L,Chronic Myeloid Leukemia,PREDICTIVE,3,1,4
BCR::ABL1 Fusion AND ABL1 F317L,Cancer,PREDICTIVE,1,1,2
BCR::ABL1 Fusion AND ABL1 F317L,Chronic Myeloid Leukemia,PREDICTIVE,20,2,22
BCR::ABL1 Fusion AND ABL1 F317V,Cancer,PREDICTIVE,1,1,2
BCR::ABL1 Fusion AND ABL1 F359C,Chronic Myeloid Leukemia,PREDICTIVE,6,4,10
BCR::ABL1 Fusion AND ABL1 F359I,Chronic Myeloid Leukemia,PREDICTIVE,1,5,6
BCR::ABL1 Fusion AND ABL1 F359V,Chronic Myeloid Leukemia,PREDICTIVE,13,5,18
BCR::ABL1 Fusion AND ABL1 F486S,Chronic Myeloid Leukemia,PREDICTIVE,5,2,7
BCR::ABL1 Fusion AND ABL1 G250E,Cancer,PREDICTIVE,2,1,3
BCR::ABL1 Fusion AND ABL1 G250E,Chronic Myeloid Leukemia,PREDICTIVE,15,3,18
BCR::ABL1 Fusion AND ABL1 H396P,Cancer,PREDICTIVE,2,1,3
BCR::ABL1 Fusion AND ABL1 H396P,Chronic Myeloid Leukemia,PREDICTIVE,5,2,7
BCR::ABL1 Fusion AND ABL1 H396R,Chronic Myeloid Leukemia,PREDICTIVE,12,3,15
BCR::ABL1 Fusion AND ABL1 L248V,Chronic Myeloid Leukemia,PREDICTIVE,7,3,10
BCR::ABL1 Fusion AND ABL1 L364I,Chronic Myeloid Leukemia,PREDICTIVE,2,1,3
BCR::ABL1 Fusion AND ABL1 L384M,Chronic Myeloid Leukemia,PREDICTIVE,5,1,6
BCR::ABL1 Fusion AND ABL1 L387M,Chronic Myeloid Leukemia,PREDICTIVE,1,2,3
BCR::ABL1 Fusion AND ABL1 M244V,Cancer,PREDICTIVE,2,1,3
BCR::ABL1 Fusion AND ABL1 M244V,Chronic Myeloid Leukemia,PREDICTIVE,7,7,14
BCR::ABL1 Fusion AND ABL1 M351T,Cancer,PREDICTIVE,1,1,2
BCR::ABL1 Fusion AND ABL1 M351T,Chronic Myeloid Leukemia,PREDICTIVE,14,4,18
BCR::ABL1 Fusion AND ABL1 N331S,Chronic Myeloid Leukemia,PREDICTIVE,1,1,2
BCR::ABL1 Fusion AND ABL1 N336S,Chronic Myeloid Leukemia,PREDICTIVE,1,1,2
BCR::ABL1 Fusion AND ABL1 Q252H,Cancer,PREDICTIVE,1,1,2
BCR::ABL1 Fusion AND ABL1 Q252H,Chronic Myeloid Leukemia,PREDICTIVE,12,3,15
BCR::ABL1 Fusion AND ABL1 Q300R,Chronic Myeloid Leukemia,PREDICTIVE,1,1,2
BCR::ABL1 Fusion AND ABL1 T315A,Cancer,PREDICTIVE,1,1,2
BCR::ABL1 Fusion AND ABL1 T315I,Acute Lymphoblastic Leukemia,PREDICTIVE,7,1,8
BCR::ABL1 Fusion AND ABL1 T315I,Chronic Myeloid Leukemia,PREDICTIVE,31,2,33
BCR::ABL1 Fusion AND ABL1 V379I,Chronic Myeloid Leukemia,PREDICTIVE,4,1,5
BCR::ABL1 Fusion AND ABL1 Y253F,Cancer,PREDICTIVE,1,1,2
BCR::ABL1 Fusion AND ABL1 Y253F,Chronic Myeloid Leukemia,PREDICTIVE,9,3,12
BCR::ABL1 Fusion AND ABL1 Y253H,Chronic Myeloid Leukemia,PREDICTIVE,9,7,16
BRAF D594G,Cancer,PREDICTIVE,1,1,2
BRAF D594G,Colorectal Cancer,PREDICTIVE,1,2,3
BRAF D594N AND BRAF G466A,Collecting Duct Carcinoma,PREDICTIVE,1,1,2
BRAF Exon 15 Mutation,Gastrointestinal Stromal Tumor,PREDICTIVE,1,1,2
BRAF G466V,Colorectal Cancer,PREDICTIVE,2,1,3
BRAF G469,Melanoma,PREDICTIVE,1,1,2
BRAF G596R,Colorectal Cancer,PREDICTIVE,1,1,2
BRAF L597,Melanoma,PREDICTIVE,2,1,3
BRAF Mutation,Colorectal Cancer,PREDICTIVE,6,1,7
BRAF N486_P490del,Solid Tumor,PREDICTIVE,1,1,2
BRAF V600,Colorectal Cancer,PREDICTIVE,6,2,8
BRAF V600E,Colorectal Cancer,PREDICTIVE,38,4,42
BRAF V600E,Colorectal Cancer,PROGNOSTIC,6,1,7
BRAF V600E,Melanoma,PREDICTIVE,39,3,42
BRAF V600E,Melanoma,PROGNOSTIC,1,1,2
BRAF V600E,Papillary Thyroid Carcinoma,PROGNOSTIC,7,1,8
BRAF V600R,Melanoma,PREDICTIVE,4,1,5
BRAF V600R,Skin Melanoma,PREDICTIVE,1,1,2
BRAF V600_K601>E,Melanoma,PREDICTIVE,1,1,2
BRAF V601E,Melanoma,PREDICTIVE,1,1,2
BRCA1 Mutation,Pancreatic Cancer,PREDICTIVE,3,3,6
BRCA2 Mutation,Pancreatic Cancer,PREDICTIVE,7,2,9
BRCA2 Mutation,Triple-receptor Negative Breast Cancer,PREDICTIVE,1,1,2
CALR EXON 9 FRAMESHIFT,Essential Thrombocythemia,PROGNOSTIC,1,1,2
CCND1 Amplification,Breast Cancer,PREDICTIVE,1,1,2
CCND1 Expression,Lung Non-small Cell Carcinoma,PROGNOSTIC,1,1,2
CCND1 Overexpression,Mantle Cell Lymphoma,PREDICTIVE,1,1,2
CCNE2 Overexpression,Breast Cancer,PREDICTIVE,1,1,2
CD274 Expression,Lung Non-small Cell Carcinoma,PROGNOSTIC,1,1,2
CD274 Expression,Melanoma,PREDICTIVE,2,1,3
CDKN2A p16 Expression,Head And Neck Squamous Cell Carcinoma,PREDICTIVE,3,2,5
CHEK2 mutation,Castration-resistant Prostate Carcinoma,PREDICTIVE,1,1,2
CTNNB1 S45F,Desmoid Tumor,PREDICTIVE,1,1,2
DLL3 Expression,Lung Small Cell Carcinoma,PREDICTIVE,1,1,2
DNMT3A R882,Acute Myeloid Leukemia,PREDICTIVE,1,1,2
DNMT3A R882,Acute Myeloid Leukemia,PROGNOSTIC,13,6,19
EGFR A767_V769dupASV,Lung Non-small Cell Carcinoma,PREDICTIVE,3,1,4
EGFR Amplification,Lung Non-small Cell Carcinoma,PREDICTIVE,5,1,6
EGFR D761N,Cancer,PREDICTIVE,1,1,2
EGFR D770_N771insNPG,Lung Non-small Cell Carcinoma,PREDICTIVE,1,1,2
EGFR D770_N771insSVD,Lung Non-small Cell Carcinoma,PREDICTIVE,2,1,3
EGFR G719A,Lung Non-small Cell Carcinoma,PREDICTIVE,4,1,5
EGFR G810S,Cancer,PREDICTIVE,1,1,2
EGFR H773_V774insH,Lung Non-small Cell Carcinoma,PREDICTIVE,1,1,2
EGFR L718Q AND EGFR L718V,Lung Adenocarcinoma,PREDICTIVE,1,1,2
EGFR L858R,Lung Adenocarcinoma,PREDICTIVE,10,1,11
EGFR L858R,Lung Non-small Cell Carcinoma,PREDICTIVE,24,1,25
EGFR Mutation,Lung Adenocarcinoma,PREDICTIVE,1,1,2
EGFR Rare Exon 18-21 Mutation,Lung Non-small Cell Carcinoma,PREDICTIVE,1,1,2
EGFR S492R,Colorectal Cancer,PREDICTIVE,6,1,7
EGFR S768I,Lung Non-small Cell Carcinoma,PREDICTIVE,5,1,6
EGFR S784F,Cancer,PREDICTIVE,1,1,2
EGFR S784F,Lung Non-small Cell Carcinoma,PREDICTIVE,1,1,2
EGFR T790M,Lung Non-small Cell Carcinoma,PREDICTIVE,30,1,31
EGFR V742A,Lung Non-small Cell Carcinoma,PREDICTIVE,1,1,2
EGFR Y764_V765insHH,Lung Non-small Cell Carcinoma,PREDICTIVE,1,1,2
EML4::ALK Fusion AND ALK C1156Y,Cancer,PREDICTIVE,3,1,4
EML4::ALK Fusion AND ALK S1206R,Cancer,PREDICTIVE,1,1,2
EML4::ALK e6::e20,Lung Non-small Cell Carcinoma,PREDICTIVE,4,3,7
ERBB2 A775_G776insYVMA ,Lung Non-small Cell Carcinoma,PREDICTIVE,2,1,3
ERBB2 Amplification,Breast Cancer,PREDICTIVE,9,1,10
ERBB2 Amplification,Colorectal Cancer,PREDICTIVE,10,2,12
ERBB2 Amplification,Her2-receptor Positive Breast Cancer,PREDICTIVE,31,3,34
ERBB2 Amplification,Lung Non-small Cell Carcinoma,PREDICTIVE,1,3,4
ERBB2 Overexpression,Gastroesophageal Junction Adenocarcinoma,PREDICTIVE,1,1,2
ERBB2 T798I,Breast Cancer,PREDICTIVE,1,2,3
ERBB2 V777L,Cancer,PREDICTIVE,3,1,4
ERBB2 Y772_A775DUP,Lung Adenocarcinoma,PREDICTIVE,3,1,4
ERBB2 Y772_A775DUP,Lung Non-small Cell Carcinoma,PREDICTIVE,3,1,4
ERCC1 Expression,Bladder Carcinoma,PREDICTIVE,1,1,2
ESR1 D538G,Breast Cancer,PREDICTIVE,3,1,4
ETV6::NTRK3 Fusion,Mammary Analogue Secretory Carcinoma,PREDICTIVE,2,1,3
FGFR1 Amplification,Breast Cancer,PREDICTIVE,12,5,17
FGFR1 Amplification,Lung Squamous Cell Carcinoma,PROGNOSTIC,2,1,3
FGFR2 Mutation,Cholangiocarcinoma,PREDICTIVE,3,1,4
FGFR3 Overexpression,Multiple Myeloma,PREDICTIVE,2,1,3
FLT3 Amplification,Colorectal Cancer,PREDICTIVE,1,2,3
FLT3 D593del,Cancer,PREDICTIVE,1,1,2
FLT3 D835V,Acute Myeloid Leukemia,PREDICTIVE,8,2,10
FLT3 D835Y,Cancer,PREDICTIVE,2,1,3
FLT3 D835Y,Leukemia,PREDICTIVE,1,1,2
FLT3 F691L,Acute Myeloid Leukemia,PREDICTIVE,12,2,14
FLT3 ITD,Acute Myeloid Leukemia,PROGNOSTIC,13,3,16
FLT3 ITD,Leukemia,PREDICTIVE,3,1,4
FLT3 Mutation,Acute Myeloid Leukemia,PROGNOSTIC,1,1,2
FLT3 Overexpression AND FLT3LG Expression,Cancer,PREDICTIVE,1,1,2
FLT3 TKD MUTATION,Acute Myeloid Leukemia,PROGNOSTIC,3,1,4
GNAQ Q209,Uveal Melanoma,PREDICTIVE,1,1,2
HRAS Q61K AND BRAF G466E,Melanoma,PREDICTIVE,1,1,2
IDH2 R140,Acute Myeloid Leukemia,PROGNOSTIC,1,2,3
IDH2 R172K,Acute Myeloid Leukemia,PROGNOSTIC,1,1,2
IGF2 Overexpression,Prostate Cancer,PREDICTIVE,2,1,3
KIF5B::RET Fusion AND RET G810A,Lung Non-small Cell Carcinoma,PREDICTIVE,1,1,2
KIT A502_Y503insAY,Cancer,PREDICTIVE,1,1,2
KIT A502_Y503insAY,Gastrointestinal Stromal Tumor,PREDICTIVE,1,1,2
KIT A829P,Gastrointestinal Stromal Tumor,PREDICTIVE,1,1,2
KIT D816E,Gastrointestinal Stromal Tumor,PREDICTIVE,1,1,2
KIT Exon 11 Mutation,Gastrointestinal Stromal Tumor,PROGNOSTIC,2,2,4
KIT K642E,Gastrointestinal Stromal Tumor,PREDICTIVE,3,1,4
KIT N822K,Acute Myeloid Leukemia,PREDICTIVE,2,2,4
KIT N822K,Gastrointestinal Stromal Tumor,PREDICTIVE,7,1,8
KIT P551_E554delPMYE,Gastrointestinal Stromal Tumor,PREDICTIVE,4,1,5
KIT T670I,Gastrointestinal Stromal Tumor,PREDICTIVE,3,2,5
KIT V560D,Cancer,PREDICTIVE,1,1,2
KRAS Exon 2 Mutation,Colorectal Cancer,PREDICTIVE,4,2,6
KRAS G12,Lung Non-small Cell Carcinoma,PROGNOSTIC,1,1,2
KRAS G12/G13,Colorectal Cancer,PREDICTIVE,4,3,7
KRAS G12/G13,Colorectal Cancer,PROGNOSTIC,1,2,3
KRAS G12/G13,Pancreatic Adenocarcinoma,PREDICTIVE,1,1,2
KRAS G12S,Colorectal Cancer,PREDICTIVE,19,1,20
KRAS G13D,Colon Cancer,PREDICTIVE,2,1,3
KRAS G13D,Colorectal Cancer,PREDICTIVE,27,2,29
KRAS Mutation,Colorectal Cancer,PREDICTIVE,13,3,16
KRAS Mutation,Lung Non-small Cell Carcinoma,PREDICTIVE,14,5,19
KRAS Wildtype,Colorectal Cancer,PREDICTIVE,3,1,4
LYN OVEREXPRESSION,Chronic Myeloid Leukemia,PREDICTIVE,1,1,2
MET Exon 14 Skipping Mutation,Lung Adenocarcinoma,PREDICTIVE,19,1,20
MET Overexpression,Skin Melanoma,PREDICTIVE,1,1,2
MTOR A2034V,Breast Cancer,PREDICTIVE,1,1,2
MTOR M2327I,Breast Cancer,PREDICTIVE,3,1,4
NF1 Loss,Malignant Peripheral Nerve Sheath Tumor,PREDICTIVE,1,1,2
NOTCH1 Mutation,Chronic Lymphocytic Leukemia,PROGNOSTIC,2,1,3
NPM1 EXON 11 MUTATION,Acute Myeloid Leukemia,PREDICTIVE,6,1,7
NPM1 EXON 11 MUTATION,Acute Myeloid Leukemia,PROGNOSTIC,15,1,16
NRAS Mutation,Melanoma,PREDICTIVE,4,2,6
NRAS Q61,Colorectal Cancer,PREDICTIVE,1,1,2
NRAS Q61,Follicular Thyroid Carcinoma,PROGNOSTIC,2,1,3
NRAS Q61K AND BRAF G466V,Lung Non-small Cell Carcinoma,PREDICTIVE,1,1,2
NT5C2 D407A,T-cell Acute Lymphoblastic Leukemia,PREDICTIVE,1,1,2
NT5C2 K359Q,T-cell Acute Lymphoblastic Leukemia,PREDICTIVE,1,1,2
NT5C2 R238W,Childhood Acute Lymphocytic Leukemia,PREDICTIVE,1,1,2
NT5C2 R367Q,Childhood Acute Lymphocytic Leukemia,PREDICTIVE,2,1,3
NT5C2 R367Q,T-cell Acute Lymphoblastic Leukemia,PREDICTIVE,2,1,3
NT5C2 S445F,Childhood Acute Lymphocytic Leukemia,PREDICTIVE,1,1,2
NUP214::ABL1 Fusion,B-lymphoblastic Leukemia/lymphoma,PREDICTIVE,2,1,3
PDGFRA D842V,Gastrointestinal Stromal Tumor,PREDICTIVE,11,1,12
PDGFRA Exon 18 Mutation,Gastrointestinal Stromal Tumor,PREDICTIVE,1,1,2
PIK3CA C420R,Her2-receptor Positive Breast Cancer,PREDICTIVE,2,1,3
PIK3CA E542K,Colorectal Cancer,PREDICTIVE,4,2,6
PIK3CA E545K,Colorectal Cancer,PREDICTIVE,4,2,6
PIK3CA E545K,Her2-receptor Positive Breast Cancer,PREDICTIVE,9,3,12
PIK3CA H1047R,Colorectal Cancer,PREDICTIVE,9,1,10
PIK3CA H1047R,Her2-receptor Positive Breast Cancer,PREDICTIVE,9,3,12
PIK3CA K111N,Her2-receptor Positive Breast Cancer,PREDICTIVE,4,3,7
PIK3CA Mutation,Cancer,PREDICTIVE,4,2,6
PIK3CA Mutation,Colorectal Cancer,PREDICTIVE,8,4,12
PIK3CA Mutation,Colorectal Cancer,PROGNOSTIC,1,1,2
PIK3CA Mutation,Endometrial Cancer,PREDICTIVE,1,1,2
PIK3CA Mutation,Head And Neck Cancer,PREDICTIVE,1,1,2
PIK3CA Mutation,Her2-receptor Positive Breast Cancer,PREDICTIVE,5,1,6
PIK3CA Mutation,Lung Non-small Cell Carcinoma,PREDICTIVE,1,1,2
PIK3CA Q546K,Colorectal Cancer,PREDICTIVE,1,1,2
PRPS1 A190T,B-lymphoblastic Leukemia/lymphoma,PREDICTIVE,2,1,3
PRPS1 D183E,B-lymphoblastic Leukemia/lymphoma,PREDICTIVE,1,1,2
PRPS1 K176N,B-lymphoblastic Leukemia/lymphoma,PREDICTIVE,1,1,2
PRPS1 L191F,B-lymphoblastic Leukemia/lymphoma,PREDICTIVE,2,1,3
PRPS1 N144S,B-lymphoblastic Leukemia/lymphoma,PREDICTIVE,2,1,3
PRPS1 S103N,B-lymphoblastic Leukemia/lymphoma,PREDICTIVE,1,1,2
PRPS1 S103T,B-lymphoblastic Leukemia/lymphoma,PREDICTIVE,2,1,3
PRPS1 T303S,B-lymphoblastic Leukemia/lymphoma,PREDICTIVE,1,1,2
PTEN Loss,Breast Cancer,PREDICTIVE,5,2,7
PTEN Loss,Cancer,PREDICTIVE,2,1,3
PTEN Loss,Colorectal Cancer,PREDICTIVE,2,1,3
PTEN Loss,Endometrial Cancer,PREDICTIVE,1,1,2
PTEN Loss,Her2-receptor Positive Breast Cancer,PREDICTIVE,14,4,18
PTEN Mutation,Glioblastoma,PREDICTIVE,1,1,2
RICTOR Amplification,Lung Small Cell Carcinoma,PREDICTIVE,1,1,2
RRM1 Underexpression,Lung Non-small Cell Carcinoma,PREDICTIVE,7,2,9
STAG2 MUTATION,Acute Myeloid Leukemia,PROGNOSTIC,1,1,2
STK11 Loss,Lung Non-small Cell Carcinoma,PREDICTIVE,11,1,12
STK11 Mutation,Lung Non-small Cell Carcinoma,PREDICTIVE,1,1,2
TET2 Mutation,Acute Myeloid Leukemia,PROGNOSTIC,4,1,5
TP53 Mutation,Head And Neck Squamous Cell Carcinoma,PROGNOSTIC,1,2,3
TP53 Truncating Mutation,Head And Neck Squamous Cell Carcinoma,PROGNOSTIC,1,1,2
U2AF1 Q157P/R,Myelodysplastic Syndrome,PROGNOSTIC,1,1,2
VHL G104V (c.311G>T),Von Hippel-Lindau Disease,PREDISPOSING,2,1,3
VHL Mutation,Renal Cell Carcinoma,PREDICTIVE,2,3,5
WT1 Exon 7 Mutation,Acute Myeloid Leukemia,PROGNOSTIC,6,2,8
WT1 Exon 9 Mutation,Acute Myeloid Leukemia,PROGNOSTIC,1,1,2
ZEB1 Expression,Mantle Cell Lymphoma,PREDICTIVE,3,1,4
v::NRG1 Fusion,Mucinous Adenocarcinoma,PREDICTIVE,1,1,2
